Treatment (ReActiv8) for Chronic Lower Back Pain
This trial will compare ReActiv8 Therapy to Optimal Medical Management (OMM) for treating people with Patellofemoral Pain Syndrome (PFPS).
- Chronic Lower Back Pain
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many participants are involved with this experiment?
"A total of 230 eligible participants are mandated for this investigation, spearheaded by Mainstay Medical. Barrow Brain & Spine in Phoenix, Arizona and Duke University in Durham, North Carolina will serve as two pivotal sites during the conduct of this trial."
Is this experimental treatment being conducted in various Canadian locations?
"This clinical trial is utilizing the resources of Barrow Brain & Spine in Phoenix, Arizona; Duke University in Durham, North Carolina; The Center for Clinical Research, LLC in Winston-Salem Oregon; and an additional 22 medical sites."
Are volunteers able to join this exploration currently?
"Affirmative, the information on clinicaltrials.gov indicates that this study is recruiting participants at present. This medical trial was initially posted July 14th 2021 and has most recently been refreshed November 9th 2022. 230 individuals are desired to partake in this experiment across 22 sites."